1. OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer
Emmet E. McGrath, MB, PhD 
Journal of Thoracic Oncology 
Volume 6, Issue 9, Pages (September 2011)
DOI: /JTO.0b013e f
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
The OPG/RANKL/RANK pathway as a therapeutic target. OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-кβ ligand; RANK, receptor activator of nuclear factor-кβ.
Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e f)
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions